From the blog

February is National Cancer Prevention Month

Cancer is the second most leading cause of death in the United States affecting over 500,000 people. However, is estimated that 1/3 of all cancers could be prevented through daily activities such as eating healthy, exercising, or simply applying sunscreen on a sunny day.  Cancers caused by asbestos exposure are[…]

Read More »

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of major pathological response.

Read More »

FDA Approves Genetic-Based Cancer Treatment that Could Help Mesothelioma Patients

Correcting genes that allow cancerous tumors to grow is the basis behind gene therapy, a relatively new treatment that is largely in experimental stages. The initial goals of gene therapy were to address hereditary genetic disorders, but other factors such as the sun, smoking, chemical exposure, etc., can all damage[…]

Read More »

UK Pharmaceutical Company’s Potential Cancer Vaccine Assists in Treating Mesothelioma

Combination treatment therapies are common for those suffering from mesothelioma because the aggressive nature of this asbestos-caused disease makes it difficult to treat effectively.  Ongoing developments and advancements in medicine have also helped mesothelioma patients extend their life and manage pain throughout the years. While there is no cure for[…]

Read More »

Determining the Exposure Limit for Asbestos

The Occupational Safety and Health Administration (OSHA) has maintained that “there is no ‘safe’ level of asbestos exposure for any type of asbestos fiber,” but despite these warnings, asbestos is still legal and still used in the United States.  Different government agencies have their own rules and regulations for asbestos[…]

Read More »

Funding Needed for Lung Cancer Awareness and Research – How You Can Help

For a cancer than claims more lives than breast, colon, and prostate cancer combined, Lung Cancer is severely underfunded, leaving scientists and researchers reliant on private funding and donations. Funding for lung cancer, as with many other cancers, plays a critical role in developing and investigating research that could eventually[…]

Read More »

A Study of Atezolizumab in Unresectable or Advanced Malignant Pleural Mesothelioma

Primary Outcome Measures Objective Response Rate [ Time Frame: From the time of initial response until documented tumor progression or death, whichever occurs first (up to approximately 4 years) ] The number of subjects whose best confirmed objective response is a CR or PR, divided by the number of treated[…]

Read More »

Dealing With a Mesothelioma Diagnosis

A mesothelioma diagnosis is devastating for those suffering with the disease and family members alike. The nature of the illness is aggressive, and there is currently no cure. The quality of life for a mesothelioma patient can decrease significantly and quickly as the cancer spreads throughout the body. One of[…]

Read More »

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso)

The aim of this clinical trial is to assess the effect of treatment with a monoclonal antibody called atezolizumab in patients diagnosed with a type of lung cancer called malignant pleural mesothelioma. The efficacy (whether the treatment works), safety and tolerability (side effects of treatment) of atezolizumab plus bevacizumab in combination with standard chemotherapy versus bevacizumab in combination with standard chemotherapy will be investigated.

Read More »